Literature DB >> 16870206

Comparative analysis of cell wall surface glycan expression in Candida albicans and Saccharomyces cerevisiae yeasts by flow cytometry.

M Martínez-Esparza1, A Sarazin, N Jouy, D Poulain, T Jouault.   

Abstract

The yeast Candida albicans is an opportunistic pathogen, part of the normal human microbial flora that causes infections in immunocompromised individuals with a high morbidity and mortality levels. Recognition of yeasts by host cells is based on components of the yeast cell wall, which are considered part of its virulence attributes. Cell wall glycans play an important role in the continuous interchange that regulates the balance between saprophytism and parasitism, and also between resistance and infection. Some of these molecular entities are expressed both by the pathogenic yeast C. albicans and by Saccharomyces cerevisiae, a related non-pathogenic yeast, involving similar molecular mechanisms and receptors for recognition. In this work we have exploited flow cytometry methods for probing surface glycans of the yeasts. We compared glycan expression by C. albicans and by S. cerevisiae, and studied the effect of culture conditions. Our results show that the expression levels of alpha- and beta-linked mannosides as well as beta-glucans can be successfully evaluated by flow cytometry methods using different antibodies independent of agglutination reactions. We also found that the surface expression pattern of beta-mannosides detected by monoclonal or polyclonal antibodies are differently modulated during the growth course. These data indicate that the yeast beta-mannosides exposed on mannoproteins and/or phospholipomannan are increased in stationary phase, whereas those linked to mannan are not affected by the yeast growth phase. The cytometric method described here represents a useful tool to investigate to what extent C. albicans is able to regulate its glycan surface expression and therefore modify its virulence properties.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16870206     DOI: 10.1016/j.jim.2006.06.004

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  5 in total

1.  The Cek1‑mediated MAP kinase pathway regulates exposure of α‑1,2 and β‑1,2‑mannosides in the cell wall of Candida albicans modulating immune recognition.

Authors:  E Román; I Correia; A Salazin; C Fradin; T Jouault; D Poulain; F-T Liu; J Pla
Journal:  Virulence       Date:  2016-05-18       Impact factor: 5.882

2.  Responses of Candida albicans to the human antimicrobial peptide LL-37.

Authors:  Pei-Wen Tsai; Yin-Lien Cheng; Wen-Ping Hsieh; Chung-Yu Lan
Journal:  J Microbiol       Date:  2014-05-30       Impact factor: 3.422

3.  Micafungin Enhances the Human Macrophage Response to Candida albicans through β-Glucan Exposure.

Authors:  José Pedro Guirao-Abad; Ruth Sánchez-Fresneda; Francisco Machado; Juan Carlos Argüelles; María Martínez-Esparza
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

4.  Development of an in vitro model for the multi-parametric quantification of the cellular interactions between Candida yeasts and phagocytes.

Authors:  Karine Dementhon; Sofiane El-Kirat-Chatel; Thierry Noël
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

5.  Protection by anti-beta-glucan antibodies is associated with restricted beta-1,3 glucan binding specificity and inhibition of fungal growth and adherence.

Authors:  Antonella Torosantucci; Paola Chiani; Carla Bromuro; Flavia De Bernardis; Angelina S Palma; Yan Liu; Giuseppina Mignogna; Bruno Maras; Marisa Colone; Annarita Stringaro; Silvia Zamboni; Ten Feizi; Antonio Cassone
Journal:  PLoS One       Date:  2009-04-28       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.